Sharon Shacham

President and Chief Scientific Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Karyopharm Therapeutics Inc. (KPTI)
Proxy statement

Start not stated–2021-05-03

Recorded roles and earnings-call appearances connecting this person to public companies.

KPTI

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Karyopharm Therapeutics Inc. (KPTI)	—	$211,934	—	$1,218,492	$3,414,984	$108,313	$1,084,066	$6,037,789
2021	Karyopharm Therapeutics Inc. (KPTI)	Ph.D., M.B.A.	$499,905	—	$832,832	$1,507,217	$249,953	$16,684	$3,106,591
2020	Karyopharm Therapeutics Inc. (KPTI)	Ph.D., M.B.A. President and ChiefScientific Officer	$483,624	—	$1,029,886	$1,920,899	$224,595	$11,880	$3,670,884
2019	Karyopharm Therapeutics Inc. (KPTI)	Ph.D., M.B.A. President and ChiefScientific Officer	$468,500	—	$803,112	$1,486,339	$250,648	$11,860	$3,020,459
2018	Karyopharm Therapeutics Inc. (KPTI)	Ph.D., M.B.A. President and Chief Scientific Officer	$450,000	—	—	$1,444,660	$183,063	$11,660	$2,089,383

No earnings-call appearances or filed executive changes recorded yet.